Elizabeth (Beth) Garner, MD, MPH
Strategic Advisor to The WHAM Research Collaborative Immediate Past President, American Medical Women’s Association (AMWA)My most recent was as the Chief Scientific Officer, Ferring US. Ferring is a leader in reproductive medicine and maternal health, uro-oncology and in specialty areas within gastroenterology, including microbiome therapeutics and orthopedics.
Prior to joining Ferring in 2022, I was the Chief Medical Officer of ObsEva, a biotechnology company focused on addressing serious unmet needs in women’s health. From 2014 to 2019, I was Chief Medical Officer of Agile Therapeutics, where I led the Phase 3 clinical development of Twirla®, Agile’s low-dose contraceptive patch.
I am the Board Chair of NUA Surgical, a start-up company developing solutions for maternal health. I am also a member of the Boards of Directors (BOD) of Kezar Life Sciences (KZR), a publicly traded company developing novel therapies for autoimmune diseases and cancer, and Sermonix Pharmaceuticals, developing targeted therapies for breast cancer. I am the Immediate-Past President and serve on the BOD of the American Medical Women’s Association, whose mission is to advance women in medicine, advocate for equity, and ensure excellence in health care.
I have extensive experience as a media spokesperson and am a frequent panelist and speaker on a range of topics including women’s health and women’s careers and leadership. I was a 2018 honoree at the Executive Women of New Jersey’s Salute to the Policy Makers gala, which recognizes executive women leaders across all industries. I am also a 2019 and 2023 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry and am the 2022 recipient of the Women in Science Award from the American Medical Women’s Association.